AXIM BIOTECHNOLOGIES, INC. Deferred Tax Liability, Intra-entity Transfer, Asset Other than Inventory
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Deferred Tax Liability, Intra-entity Transfer, Asset Other than Inventory of $2.34 million as of 2020-12-31, per its 10-K/A filed 2021-04-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilityIntraEntityTransferAssetOtherThanInventory · last filed 2021-04-26
- 2020-12-31: Deferred Tax Liability, Intra-entity Transfer, Asset Other than Inventory $2.34M.
- 2020-03-31: Deferred Tax Liability, Intra-entity Transfer, Asset Other than Inventory $1.84M.
- 2019-12-31: Deferred Tax Liability, Intra-entity Transfer, Asset Other than Inventory $0.00.
| Period end | Deferred Tax Liability, Intra-entity Transfer, Asset Other than Inventory |
|---|---|
| 2020-12-31 | $2.34M 10-K/A · filed 2021-04-26 |
| 2020-03-31 | $1.84M 10-Q/A · filed 2020-07-02 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-26 |